These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21838595)

  • 41. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor alpha agonist in preclinical species and human.
    Frederick KS; Maurer TS; Kalgutkar AS; Royer LJ; Francone OL; Winter SM; Terra SG; Chen D; Gao X
    Xenobiotica; 2009 Oct; 39(10):766-81. PubMed ID: 19622022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of pharmacokinetics, brain levels and protein binding of centpropazine in rats.
    Bhattaram VA; Paliwal JK; Gupta RC
    Biopharm Drug Dispos; 2004 Mar; 25(2):69-75. PubMed ID: 14872554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic fate of the novel antihypertensive drug naftopidil.
    Peter G; Niebch G; Locher M; Borbe HO
    Arzneimittelforschung; 1991 Sep; 41(9):924-31. PubMed ID: 1796920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W; Ahr HJ; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of a novel histone deacetylase inhibitor, apicidin, in rats.
    Shin BS; Chang HS; Park EH; Yoon CH; Kim HY; Kim J; Ryu JK; Zee OP; Lee KC; Cao D; Yoo SD
    Biopharm Drug Dispos; 2006 Mar; 27(2):69-75. PubMed ID: 16299816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats.
    Bohlooli S; Keyhanfar F; Mahmoudian M
    Biopharm Drug Dispos; 2004 May; 25(4):187-91. PubMed ID: 15108221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue concentrations and pharmacokinetics of florfenicol in broiler chickens.
    Afifi NA; EL-SOOUD KA
    Dtsch Tierarztl Wochenschr; 1997 May; 104(5):178-80. PubMed ID: 9200888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats.
    Kim YH; Yoo SD; Kim YS; Lee KH; Lee HS
    Biopharm Drug Dispos; 2007 Nov; 28(8):423-9. PubMed ID: 17828714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tissue concentrations and pharmacokinetics of florfenicol in broiler chickens.
    Afifi NA; Abo el-Sooud KA
    Br Poult Sci; 1997 Sep; 38(4):425-8. PubMed ID: 9347153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and pharmacodynamics of idrapril in rats, dogs, and humans.
    Criscuoli M; Lippi A; Mengozzi G; Sardelli G; Subissi A; Giachetti A
    Drug Metab Dispos; 1993; 21(5):835-40. PubMed ID: 7902245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics, biliary excretion, and tissue distribution of novel anti-HIV agents, cosalane and dihydrocosalane, in Sprague-Dawley rats.
    Kuchimanchi KR; Udata C; Johnston TP; Mitra AK
    Drug Metab Dispos; 2000 Apr; 28(4):403-8. PubMed ID: 10725308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics, tissue distribution, and excretion of sitafloxacin, a new fluoroquinolone antibiotic, in rats, dogs, and monkeys.
    Tachibana M; Tanaka M; Mitsugi K; Jin Y; Takaichi M; Okazaki O
    Arzneimittelforschung; 2004; 54(12):898-905. PubMed ID: 15646375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress.
    Fumagalli F; Calabrese F; Luoni A; Bolis F; Racagni G; Riva MA
    Int J Neuropsychopharmacol; 2012 Mar; 15(2):235-46. PubMed ID: 21349227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dose-independent pharmacokinetics of a new peroxisome proliferator-activated receptor-γ agonist, KR-62980, in Sprague-Dawley rats and ICR mice.
    Park JS; Kim MS; Song JS; Choi SH; Lee BH; Woo J; Ahn JH; Bae MA; Ahn SH
    Arch Pharm Res; 2011 Dec; 34(12):2051-8. PubMed ID: 22210030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetic characterization of the novel TAZ modulator TM-25659 using a multicompartment kinetic model in rats and a possibility of its drug-drug interactions in humans.
    Lee KR; Choi SH; Song JS; Kwak EY; Chae YJ; Im SH; Lee BH; Seo H; Cho WK; Kim MS; Kim NJ; Ahn SH; Bae MA
    Xenobiotica; 2013 Feb; 43(2):193-200. PubMed ID: 22856387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The preclinical profile of lurasidone: clinical relevance for the treatment of schizophrenia.
    Tarazi FI; Riva MA
    Expert Opin Drug Discov; 2013 Oct; 8(10):1297-307. PubMed ID: 23837554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid.
    Calabrese F; Luoni A; Guidotti G; Racagni G; Fumagalli F; Riva MA
    Psychopharmacology (Berl); 2013 Mar; 226(1):101-12. PubMed ID: 23093383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.